Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People's Republic of China. It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is neutral on EV/EBITDA.
Target Price
The average target price of 6622.HK is 2.5 and suggests 30% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
Buy
Sell